Stay updated on EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page.

Latest updates to the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page
- Check5 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a new version of the page. This change usually accompanies minor fixes or updates without altering the study details.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing Revision: v3.5.3. This indicates a minor update to the page version rather than any substantive change to study content.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision updated from v3.5.2 to v3.5.3, indicating a newer release of the page content.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page now displays Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

- Check69 days agoChange DetectedAdded the Squamous cell carcinoma of the head and neck term and a Resources entry linking to the Genetic and Rare Diseases Information Center.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

Stay in the know with updates to EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page.